DIA Europe 2022

Startdatum: 29 March 2022
Einddatum: 31 March 2022
Tijd: 00:00 - 00:00
Locatie: Hybride (Brussel)

DIA Europe 2022 is designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need for your everyday job. Your participation will accelerate your growth and your organization's performance in the drug development ecosystem.

Continue Reading

EMA Clinical Trial Information System (CTIS) webinar: dynamic demo of sponsor workspace

Datum: 21 September 2021
Tijd: 00:00 - 00:00
Locatie: Virtueel

This webinar provides a demonstration of the current status of the Clinical Trials Information System (CTIS) which is currently under development, combining presentations and discussions on the underlying principles and concepts with demonstrations of specific functionalities. After a brief introduction and overview of CTIS, the workspace functionalities that are specifically designed for use by clinical trial sponsors, including commercial and non-commercial (academic) sponsors will be demonstrated.

Continue Reading

DIA: Clinical Trial Regulation Conference

Startdatum: 1 December 2021
Einddatum: 2 December 2021
Tijd: 00:00 - 00:00
Locatie: Virtual

This conference will focus on the differences between the present and new requirements for managing clinical trials in the face of forthcoming changes, including the new EU clinical trials Regulation but also conducting novel complex innovative design trials. Regulators and other decision-makers, together with various experts in the field, will debate how the new legislation will impact the processes for the design, submission and approval, and managing European clinical trials in the future.

Continue Reading

DIA: Clinical Trial Regulation Conference

Startdatum: 18 November 2020
Einddatum: 19 November 2020
Tijd: 00:00 - 00:00
Locatie: Online

This conference will focus on the differences between the present and new requirements for managing clinical trials in the face of forthcoming changes, including the new EU clinical trials Regulation but also conducting novel complex innovative design trials. Regulators and other decision-makers, together with various experts in the field, will debate how the new legislation will impact the processes for the design, submission and approval, and managing European clinical trials in the future.

Featured topics
• Status of the CTR
• Ethics Committee preparedness for CTR
• Update on national pilots from MS
• Innovative Trial Designs and their Management
• GDPR and its consequences for Clinical Trials
• Member States preparedness for the regulation, including plans for co-operation between agencies and ethics committees and coordinated assessment
• Considerations for the preparation of applications and notifications by sponsors

Continue Reading

DIA: Global Clinical Trial Disclosure & Data Transparency Conference

Startdatum: 16 November 2020
Einddatum: 18 November 2020
Tijd: 00:00 - 00:00
Locatie: Online

The 2020 Conference builds on prior very successful conference series and leverages learnings from Regulators and international experts in the field. Clinical trial sponsors and academia are facing a host of new registration requirements in the EU, USA, and elsewhere. With evolving requirements comes new challenges, creating additional opportunities for knowledge-sharing and necessitating more interaction with peers. This event will provide essentials and timely information about global clinical trial disclosure and data transparency. It brings leading study sponsors from Industry and Academia to exchange knowledge and share their experiences with the implementation of Clinical Trial and Data Transparency from an academic and an industry viewpoint.

Continue Reading

EFGCP & DIA: Better Medicines for Children Conference

Startdatum: 12 October 2020
Einddatum: 13 October 2020
Tijd: 00:00 - 00:00
Locatie: Online

This year, in 2020, 13 years after the EU Paediatric Regulation came into force, our aim is to build on achievements and lessons learnt so far and to look at the future of paediatric drug development, with a specific focus on putting patients at the heart of innovation and regulatory science.

Continue Reading